Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2968
Full Text
Open PDFAbstract
Available in full text
Date
April 26, 2017
Authors
Publisher
American Association for Cancer Research (AACR)